上野 彰久

Medicine & Life Sciences

1. Adenocarcinoma 14%
2. Angiogenesis Inducing Agents 9%
3. Anions 14%
4. Artifacts 12%
5. Bile Duct Neoplasms 10%
6. Bile Ducts 16%
7. C Chemokines 25%
8. Catenins 37%
9. CC chemokine receptor 9 27%
10. CC Chemokines 12%
11. Cell Count 9%
12. Chemokine Receptors 29%
13. Cholangiocarcinoma 22%
14. Choledochal Cyst 18%
15. Collagen 20%
16. Communication 9%
17. Coronary Vessels 10%
18. Dendritic Cells 11%
19. Elastin 15%
20. Endometrial Neoplasms 13%
21. Fats 9%
22. Fatty Liver 15%
23. Fibroblasts 11%
24. Frozen Sections 14%
25. gadolinium ethoxybenzyl DTPA 59%
26. Hepatitis C 15%
27. Hepatocellular Carcinoma 100%
28. Hepatocytes 12%
29. Lipoma 15%
30. Liver 24%
31. Liver Neoplasms 16%
32. Magnetic Resonance Imaging 28%
33. Mutation 8%
34. Neoadjuvant Therapy 15%
35. Neoplasm Metastasis 7%
36. Neoplasms 49%
37. Pancreatic Intraductal Neoplasms 20%
38. Pancreatic Neoplasms 42%
39. Pathology 8%
40. Peptides 8%
41. Perilipin-1 20%
42. Perilipin-2 21%
43. Sorafenib 16%
44. Survival 10%
45. Syringes 8%
46. T-Lymphocytes 11%
47. Telomerase 15%
48. Therapeutics 7%
49. Tomography 29%
50. Tumor Microenvironment 14%